Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Benchmark Mark Palmer started coverage of Semler Scientific (SMLR) with the assessment of purchase and price goal $ 101, with quoting a dramatic company of the company from medical diagnostics to bitcoins
Accumulation as a key control controller.
Semler, who spent more than 15 years focused on the detection of chronic diseases, adopted bitcoin as its primary asset of the Treasury of the Treasury in May last year.
This step made it only the second company on the US list, after Michael Saylor’s strategy (Mst)to accept bitcoins as a treasury reserve asset.
Since then, the company has received approximately $ 4,636 for $ 430 million, with an average cost base of $ 92,753 per bitcoin, it is reported.
Palmer noted that the shares gathered by 178% in six and a half months after his bitcoin standard announcement, in December 2024 they reached a peak at $ 81.56. However, the analyst claimed that Semler still trades a steep discount compared to Bitcoin’s cash registers.
Its multiple of net value of assets (Mnav) Sitting at 1.25, compared to 4.29 for Japan based in a metaplanet based in Japan (3350) and 6.45 for the French group Blockchain (Altbg)The analyst noted.
Benchmark believes that this gap could be closed. The management recently appointed Joe Burnett as the director of the Bitcoin Strategy and outlined the bold objectives of BTC accumulation: 10,000 BTC by the end of 2025, 42,000 until the end of 2026 and 105,000 until the end of 2027.
The report states that the solution of legal and regulatory winds from Semler’s older medical business, including the Ministry of Justice (Impressed) Investigations and reimbursement of Medicare uncertainty could help increase its award further.
Benchmark $ 101’s price goal is based on the award of the amount of parties that assume that Bitcoin will hit $ 225,000 by the end of 2026.
Read more: Semler Scientific Trades at Bitcoin Holdings bonus for the first time in three weeks
